Provided by Tiger Fintech (Singapore) Pte. Ltd.

Apellis Pharmaceuticals Inc.

26.00
+0.95003.79%
Pre-market: 26.500.5000+1.92%08:01 EST
Volume:1.19M
Turnover:30.70M
Market Cap:3.26B
PE:-16.28
High:26.15
Open:25.21
Low:24.75
Close:25.05
Loading ...

Sector Update: Health Care Stocks Edge Higher Pre-Bell Tuesday

MT Newswires Live
·
28 Jan

Apellis Pharmaceuticals' Geographic Atrophy Treatment Gets Approval From Australian Therapeutic Goods Administration

MT Newswires Live
·
28 Jan

Australia’s TGA approves Apellis’ SYFOVRE for GA related to AMD

TIPRANKS
·
28 Jan

Apellis Receives Approval of Syfovre® (Pegcetacoplan) in Australia for Geographic Atrophy (Ga)

THOMSON REUTERS
·
28 Jan

Apellis Receives Approval of SYFOVRE® (pegcetacoplan) in Australia for Geographic Atrophy (GA)

GlobeNewswire
·
28 Jan

Wedbush Raises Price Target on Apellis Pharmaceuticals to $30 From $25, Keeps Neutral Rating

MT Newswires Live
·
23 Jan

Apellis Pharmaceuticals Price Target Maintained With a $26.00/Share by RBC Capital

Dow Jones
·
22 Jan

Apellis Pharmaceuticals Price Target Maintained With a $57.00/Share by HC Wainwright & Co.

Dow Jones
·
14 Jan

Apellis’ Syfovre can capitalize on competitor headwinds, says JPMorgan

TIPRANKS
·
14 Jan

Apellis Shares Rise After Reporting Preliminary Q4, Full-Year Product Sales Results

MT Newswires Live
·
14 Jan

Apellis Highlights Commercial Growth and Strategic Priorities at 43Rd Annual J.p. Morgan Healthcare Conference

THOMSON REUTERS
·
13 Jan

Press Release: Apellis Highlights Commercial Growth and Strategic Priorities at 43rd Annual J.P. Morgan Healthcare Conference

Dow Jones
·
13 Jan

Apellis appoints Keli Walbert to board of directors

TIPRANKS
·
10 Jan

Apellis Announces Keli Walbert to Join the Board of Directors

THOMSON REUTERS
·
10 Jan

Apellis Pharmaceuticals Inc - Board Expands to Seven Directors, Six Independent

THOMSON REUTERS
·
10 Jan

Press Release: Apellis Announces Keli Walbert to Join the Board of Directors

Dow Jones
·
10 Jan